Cargando…
Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems
Adverse drug reactions (ADRs) restrict the maximum doses applicable in chemotherapy, which leads to failure in cancer treatment. Various approaches, including nano-drug and prodrug strategies aimed at reducing ADRs, have been developed, but these strategies have their own pitfalls. A renovated strat...
Autores principales: | Yao, Qingxin, Lin, Feng, Fan, Xinyuan, Wang, Yanpu, Liu, Ye, Liu, Zhaofei, Jiang, Xingyu, Chen, Peng R., Gao, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261997/ https://www.ncbi.nlm.nih.gov/pubmed/30487642 http://dx.doi.org/10.1038/s41467-018-07490-6 |
Ejemplares similares
-
Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018) -
Bioorthogonal Chemical Activation of Kinases in Living
Systems
por: Zhang, Gong, et al.
Publicado: (2016) -
Bioorthogonal activation of prodrugs, for the potential treatment of breast cancer, using the Staudinger reaction
por: Mitry, Madonna M. A., et al.
Publicado: (2023) -
Activation and Delivery of Tetrazine-Responsive Bioorthogonal Prodrugs
por: Wang, Yayue, et al.
Publicado: (2020) -
Coordinating bioorthogonal reactions with two tumor-microenvironment-responsive nanovehicles for spatiotemporally controlled prodrug activation
por: Zuo, Liping, et al.
Publicado: (2020)